Johnson & Johnson (NYSE:JNJ)

101.70
BATS BZX Real-Time Price
As of 12:32pm ET
 -0.73 / -0.71%
Today’s Change
95.10
Today|||52-Week Range
109.49
-2.75%
Year-to-Date
3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog
11:56am / Zacks.com
J&J Announces Pharma Unit Will Continue Driving Above-Industry Growth with Plans to F...
May 20 / Benzinga
Investment Clubs -- Can You Boost Retirement Savings With a Social Network?
9:39am / TheStreet.com
The 30 Dow Jones Stocks
May 18 / MotleyFool.com
Reckitt faces regulatory friction in UK over K-Y acquisition
6:01am / FT.com
Apple Inc. Wants Your DNA, but Why?
May 18 / MotleyFool.com
J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog
May 21 / Zacks.com
Celgene's Crohn's Disease Drug Prompts Lingering Questions
May 18 / TheStreet.com
Johnson & Johnson Just Stepped Up Its Hepatitis C Game
May 21 / MotleyFool.com
J&J's Janssen Reports Data Demonstrates Adults with Type 2 Diabetes Achieved Blood Gl...
May 18 / Benzinga
PerkinElmer Hits 52-Week High on Strong Q1, Favorable View - Analyst Blog
May 21 / Zacks.com
Endo to buy Par from TPG Capital in in $8bn deal
May 18 / FT.com
S&P 500 Index Futures Trading Higher
May 21 / Benzinga
UPS, CSCO, IBM, CI: Jim Cramer's Views
May 18 / TheStreet.com
The Most Popular Stocks Held By 4 Different Generations Of Investors
May 21 / Benzinga
The Week Ahead: Picture Gets Clearer
May 17 / TheStreet.com
3 Big Pharmaceutical Stocks to Buy Right Now
May 21 / TheStreet.com
The FDA's Authority Challenged By Mallinckrodt
May 15 / Benzinga
Following Hepatitis C, This Could Be the Next Disease Researchers Cure
May 21 / MotleyFool.com
3 Reasons Not to Be Gloomy About the Stock Market
May 15 / TheStreet.com
Apple or Microsoft? How to Build a One-Stock Portfolio
May 21 / TheStreet.com
Good Reasons Not to Be Gloomy
May 15 / TheStreet.com
Johnson & Johnson Takes On Gilead Sciences in Hep C... Again
May 20 / MotleyFool.com
These Charts Explain Why Johnson & Johnson Should Be Approached Tactically
May 15 / Benzinga
Achillion and Johnson & Johnson in $1.1B HCV Tie-Up - Analyst Blog
May 20 / Zacks.com
Most popular stocks: Millennials vs. Boomers
May 14 / CNNMoney.com
Johnson & Johnson Plans for 10 New Drugs -- Is It Time to Own the Stock?
May 20 / TheStreet.com
Dividend Stocks: What You Need to Know
May 13 / MotleyFool.com
Johnson & Johnson's $10 Billion Plan for 10 New Drugs by 2019
May 20 / TheStreet.com
Johnson & Johnson's Invega Sustenna sNDA Suffers Setback - Analyst Blog
May 12 / Zacks.com
GlaxoSmithKline plc (ADR)(GSK): A Big Pharma Stock With A Very Big Dividend
May 20 / Investing Channel
5 Largest Markets for Pharmaceuticals
May 12 / MotleyFool.com
Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing
May 20 / MotleyFool.com
European drugmakers lifted by weak euro
Apr 30 / FT.com
Morning Market Losers
May 20 / Benzinga
Chinese chase Australian opiates in Hong Kong
Apr 29 / FT.com
Benzinga's Top #PreMarket Losers
May 20 / Benzinga
Apple set to be latest to suffer dollar impact
Apr 26 / FT.com
Stocks Rise as Banks Settle With DOJ, Crude Rallies
May 20 / TheStreet.com
Lowered expectations rewards US earnings
Apr 24 / FT.com
Will Johnson & Johnson (JNJ) Stock be Helped by New Drug Lineup Plan?
May 20 / TheStreet.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account